Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications
Genomic testing and patient rights.
Journal: Journal of the National Cancer Institute
Published: February 02, 2024
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Journal: Leukemia
Published: May 22, 2023
Ethics and Clinical Research: Improving Transparency and Informed Consent in Phase I Oncology Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 01, 2023
Systematic review and meta-analysis: Prognostic impact of time from diagnosis to treatment in patients with acute myeloid leukemia.
Journal: Cancer
Published: December 06, 2022
The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?
Journal: EJHaem
Published: September 22, 2021
Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial.
Journal: Leukemia research
Published: June 11, 2021
Advances in therapeutic options for newly diagnosed, high-risk AML patients.
Journal: Therapeutic advances in hematology
Published: February 14, 2021
Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.
Journal: Bone marrow transplantation
Published: September 10, 2020
Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia.
Journal: Leukemia research
Published: September 04, 2020
CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia.
Journal: Cancer research
Published: May 31, 2020
Last Updated: 09/26/2026